


@article{brinkmann:2017,
author="Brinkmann, U. and Kontermann, R. E. ",
year="2017",
title="The making of bispecific antibodies",
journal="MAbs",
volume="9",
issue="2",
pages="182--212",
doi="10.1080/19420862.2016.1268307"
}

@article{fan:2015,
author="Fan, G. and Wang, Z. and Hao, M. and Li, J. ",
year="2015",
title="Bispecific antibodies and their applications",
journal="Journal of Hematology and Oncology",
volume="8",
issue=1,
pages="130",
doi="10.1186/s13045-015-0227-0"
}

@article{gunasekaran:2010,
author="Gunasekaran, K. and Pentony, M. and Shen, M. and Garrett, L. and Forte, C. and 
        Woodward, A. and Ng, S. Bin and Born, T. and Retter, M. and Manchulenko, K. and 
        Sweet, H. and Foltz, I. N. and Wittekind, M. and Yan, W.",
year="2010",
title="Enhancing Antibody {Fc} Heterodimer Formation through Electrostatic Steering 
       Effects: {A}pplications to Bispecific Molecules and Monovalent {IgG}",
journal="Journal of Biological Chemistry",
volume="285",
issue=25,
pages="19637--19646",
doi="10.1074/jbc.M110.117382"
}

@article{kontermann:2011,
author="Kontermann, R. E. ",
year="2011",
title="Strategies for extended serum half-life of protein therapeutics",
journal="Current Opinion in Biotechnology",
volume="22",
issue=6,
pages="868--876",
doi="10.1016/j.copbio.2011.06.012"
}

@article{kontermann:2015,
author="Kontermann, R. E. and Brinkmann, U. ",
year="2015",
title="Bispecific antibodies",
journal="Drug Discovery Today",
volume="20",
issue=7,
pages="838--847",
doi="10.1016/j.drudis.2015.02.008"
}

@article{labrijn:2019,
author="Labrijn, A. F. and Janmaat, M. L. and Reichert, J. M. and Parren, P. W. H. I. ",
year="2019",
title="Bispecific antibodies: a mechanistic review of the pipeline",
journal="Nature Reviews Drug Discovery",
volume="18",
issue=8,
pages="585--608",
doi="10.1038/s41573-019-0028-1"
}

@article{legall:1999,
author="Le Gall, F. and Kipriyanov, S. M. and Moldenhauer, G. and Little, M.",
year=1999,
title="Di-, tri- and tetrameric single chain {Fv} antibody fragments against 
       human {CD19}: effect of valency on cell binding",
journal="FEBS Letters",
volume="453",
issue="1--2",
pages="164--168",
doi="10.1016/S0014-5793(99)00713-9"
}

@article{ma:2021,
author="Ma, J. and Mo, Y. and Tang, M. and Shen, J. and Qi, Y. and
        Zhao, W. and Huang, Y. and Xu, Y. and Qian, C. ",
year="2021",
title="Bispecific Antibodies: From Research to Clinical Application",
journal="Frontiers in Immunology",
volume=12,
pages="626616",
doi="10.3389/fimmu.2021.626616"
}

@article{milstein:1983,
author="Milstein, C. and Cuello, A. C.",
year="1983",
title="Hybrid hybridomas and their use in immunohistochemistry",
journal="Nature",
volume="305",
issue=5934,
pages="537--540",
doi="10.1038/305537a0"
}

@article{ridgway:1996,
author="Ridgway, J. B. B. and Presta, L. G. and Carter, P.",
year="1996",
title="`Knobs-into-holes' engineering of antibody {CH3} domains for
       heavy chain heterodimerization",
journal="Protein Engineering, Design and Selection",
volume="9",
issue=7,
pages="617--621",
doi="10.1093/protein/9.7.617"
}

@article{sau:2017,
author="Sau, S. and Alsaab, H. O. and Kashaw, S. K. and Tatiparti, K. and Iyer, A. K. ",
year="2017",
title="Advances in antibody-drug conjugates: A new era of targeted cancer therapy",
journal="Drug Discovery Today",
volume="22",
issue=10,
pages="1547--1556",
doi="10.1016/j.drudis.2017.05.011"
}

@article{schmitt:2021,
author="Schmitt, C. and Adamkewicz, J. I. and Xu, J. and Petry, C. and Catalani, O. and Young, G. and Negrier, C. and Callaghan, M. U. and Levy, G. G. ",
year="2021",
title="Pharmacokinetics and Pharmacodynamics of Emicizumab in Persons with Hemophilia~{A} with Factor~{VIII} Inhibitors: {HAVEN~1} Study",
journal="Thrombosis and Haemostasis",
volume="121",
issue=3,
pages="351--360",
doi="10.1055/s-0040-1717114"
}

@article{seimetz:2011,
author="Seimetz, D. ",
year="2011",
title="Novel monoclonal antibodies for cancer treatment: the trifunctional antibody catumaxomab (removab)",
journal="Journal of Cancer",
volume=2,
pages="309--316",
doi="10.7150/jca.2.309"
}

@article{spiess:2015,
author="Spiess, C. and Zhai, Q. and Carter, P. J. ",
year="2015",
title="Alternative molecular formats and therapeutic applications for bispecific antibodies",
journal="Molecular Immunology",
volume=67,
issue="2, Part A",
pages="95--106",
doi="10.1016/j.molimm.2015.01.003"
}

@article{szijj:2021,
author="Szijj, P. and Chudasama, V. ",
year="2021",
title="The renaissance of chemically generated bispecific antibodies",
journal="Nature Reviews Chemistry",
volume="5",
issue=2,
pages="78--92",
doi="10.1038/s41570-020-00241-6"
}

@article{wilke:2017,
author="Wilke, A. C. and G{\"{o}}kbuget, N.",
year="2017",
title="Clinical applications and safety evaluation of the new {CD19} specific {T-cell} engager antibody construct blinatumomab",
journal="Expert Opinion on Drug Safety",
volume="16",
issue=10,
pages="1191--1202",
doi="10.1080/14740338.2017.1338270"
}

@article{zhang:2012,
author="Zhang, T. and Li, H. and Xi, H. and Stanton, R. V. and Rotstein, S. H. ",
year="2012",
title="{HELM}: A Hierarchical Notation Language for Complex Biomolecule Structure Representation",
journal="Journal of Chemical Information and Modeling",
volume="52",
issue=10,
pages="2796--2806",
doi="10.1021/ci3001925"
}

@article{weininger:smiles,
author="Weininger, D.",
year=1988,
title="{SMILES}, a chemical language and information system. 1. {I}ntroduction to methodology and encoding rules",
journal="J. Chem. Inf. Comput. Sci.",
volume=28,
issue=1,
pages="31â€“36",
doi="10.1021/ci00057a005"
}

@article{adams:bimekizumab,
author="Adams, Ralph and Maroof, Asher and Baker, Terry and Lawson, Alastair D. G. and 
        Oliver, Ruth and Paveley, Ross and Rapecki, Steve and Shaw, Stevan and 
        Vajjah, Pavan and West, Shauna and Griffiths, Meryn",    
title="Bimekizumab, a Novel Humanized {IgG1} Antibody That Neutralizes Both {IL-17A} and {IL-17F}",      
journal="Frontiers in Immunology",      
volume="11",      
year="2020",      
url="https://www.frontiersin.org/article/10.3389/fimmu.2020.01894",       
note="doi:10.3389/fimmu.2020.01894",      
doi="10.3389/fimmu.2020.01894"
}
